Relationship between mean platelet volume and left ventricular systolic function in patients with metabolic syndrome and ST-elevation myocardial infarction

Clinical and Investigative Medicine

Volumn 34, Issue 6, 2011, Pages

  Yazici, Huseyin U ^a   Poyraz, Fatih ^a   Sen, Nihat ^a   Tavil, Yusuf ^a   Turfan, Murat ^a   Tulmaç, Murat ^a   Abaci, Adnan ^a  

^a GAZI UNIVERSITY FACULTY OF MEDICINE   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; ELECTROCARDIOGRAPHY; HEART INFARCTION; HEART LEFT VENTRICLE FUNCTION; HUMAN; MALE; METABOLIC SYNDROME X; METHODOLOGY; MIDDLE AGED; PATHOLOGY; PATHOPHYSIOLOGY; PROGNOSIS; STATISTICAL MODEL; STATISTICS; THROMBOCYTE; THROMBOCYTE COUNT;

AGED; BLOOD PLATELETS; ELECTROCARDIOGRAPHY; HUMANS; LOGISTIC MODELS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; MYOCARDIAL INFARCTION; PLATELET COUNT; PROGNOSIS; VENTRICULAR FUNCTION, LEFT;

EID: 84858592592     PISSN: 0147958X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults. Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 2001;285:2486-97.
2. Isomaa B, Almgren P, Tuomi T, Forsén B, Lahti K, Nissén M, Taskinen MR, Groop L.Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 2001;24:683-9.
3. Trevisan M, Liu J, Bahsas FB, Menotti A. Syndrome X and mortality: a population-based study. Am J Epidemiol, 1998;148:958-966.
4. Nieuwdorp M, Stroes ESG, Meijers JCM, Büller H. Hypercoagulability in the metabolic syndrome. Curr Opin Pharmacol 2005;5:155-9.
5. Park Y, Schoene N, Harris W. Mean platelet volume as an indicator of platelet activation: methodological issues. Platelets 2002;13:301-6.
6. Thiara S, Elisaf M, Jagroob IA, Mikhailidis DP. Platelets as predictors of vascular risk: is there a practical index of platelet activity? Clin Appl Thromb Hemost 2003;9:177-90.
7. Endler G, Klimesch A, Sunder-Plassmann H, Schillinger M, Exner M, Mannhalter C, Jordanova N, Christ G, Thalhammer R, Huber K, Sunder-Plassmann R. Mean platelet volume is an independent risk factor for myocardial infarction but not for coronary artery disease. Br J Haematol 2002;117:399-404.
8. Martin JF, Bath PM, Burr ML. Influence of platelet size on outcome after myocardial infarction. Lancet 1991; 338:1409-1411.
9. Bigger JT, Fleiss JL, Kleiger R, Miller JP, Rolnitzky LM and the Multicenter Post-Infarction Research Group. The relationships among ventricular arrhythmias, left ventricular dysfunction and mortality in the 2 years after myocardial infarction. Circulation 1984;69:250-
10. Schiller NB, Shah PM, Crawford M, De Maria A, Devereux R, Feigenbaum H, Gutgesell H, Reichek N, Sahn D, Schnittger I. Recommendations for quantization of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantization of Two-Dimensional Echocardiograms. J Am Soc Echocardiography 1989;2:358-367.
11. Thaulow E, Eriksen J, Sandvik L, Stormorken H, Cohn PF. Blood platelet count and function are related to total and cardiovascular death in apparently healthy men. Circulation 1991;84:613-17.
12. Tavil Y, §en N, Yazici HU, Hizal F, Abaci A, Cengel A. Mean platelet volume in patients with metabolic syndrome and its relationship with coronary artery disease. Thrombosis Research 2007;120:245-50.
13. Papanas N, Symeonidis G, Maltezos E, Mavridis G, Karavageli E, Vosnakidis T, Lakasas G. Mean platelet volume in patients with type 2 diabetes mellitus. Platelets 2004; 15:475-478.
14. Çoban E, Yazicioglu G, Berkant Avci A, Akçit F. The mean platelet volume in patients with essential and with coat hypertension. Platelets, 2005;16:435-438.
15. Nadar SK, Blann AD, Kamath S, Beevers DG, Lip GY. Platelet indexes in relation to target organ damage in high-risk hypertensive patients a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT). J Am Coll Cardiol 2004;44:415-22.
16. Rewers M, Zaccaro D, DAgostino R, Haffner S, Saad MF, Selby JV. Insulin sensitivity, insulinemia, and coronary artery disease: the insulin resistance atherosclerosis study. Diabetes Care 2004;27:781-7.
17. Kip KE, Marroquin OC, Kelley DE, Johnson BD, Kelsey SF, Shaw LJ, Rogers WJ, Reis SE. Clinical importance of obesity versus the metabolic syndrome in cardiovascular risk in women: a report from the Women's Ischemia Syndrome Evaluation (WISE) Study. Circulation 2004;109:706-13.
18. Iwakura K, Ito H, Ikushima M, Kawano S, Okamura A, Asano K, Kuroda T, Tanaka K, Masuyama T, Hori M, Fujii K. Association between hyperglycemia and the no reflow phenomenon in patients with acute myocardial infarction. J Am Coll Cardiol 2003;41:1-7.
19. Lim HS, Blann AD, Lip GY. Soluble CD40 ligand, soluble P selectin, interleukin-6, and tissue factor in diabetes mellitus: relationships to cardiovascular disease and risk factor intervention. Circulation 2004;109:2524-8.
20. Davi G, Catalano I, Averna M, Notarbartolo A, Strano A, Ci-abattoni G, Patrono C. Thromboxane biosynthesis and platelet function in type II diabetes mellitus. N Engl J Med 1990; 322:1769-74.
21. Keating FK, Sobel BE, Schneider DJ. Effects of increased concentrations of glucose on platelet reactivity in healthy subjects and in patients with and without diabetes mellitus. Am J Cardiol 2003;92:1362-5.
22. Honing ML, Morrison PJ, Banga JD, Stroes ES, Rabelink TJ. Nitric oxide availability in diabetes mellitus. Diabetes Metab Rev 1998;14:241-9.
23. Threatte GA. Usefulness of the mean platelet volume. Clin Lab Med 1993; 13(4):937-950.
24. Martin JF, Trowbridge EA, Salmon G, Plumb J. The biological significance of platelet volume: its relationship to bleeding time, thromboxane B2 production and megakaryocyte nuclear DNA concentration. Thromb Res 1983;32:443-60.
25. Erhart S, Beer JH, Reinhart WH. Influence of aspirin on platelet count and volume in humans. Acta Haematol 1999;101:140-4.
26. Pizzulli L, Yang A, Martin JF, Luderitz B: Changes in platelet size and count in unstable angina compared to stable angina or non-cardiac chest pain. Eur Heart J 1998;19:80-84.
27. Sen N, Basar N, Maden O, Ozcan F, Ozlu MF, Gungor O, Cagli K, Erbay AR, Balbay Y. Increased mean platelet volume in patients with slow coronary flow. Platelets 2009;20:23-28.
28. §en N, Tavil Y, Yazici HU, Hizal F, Açikgöz SK, Abaci A, Cengel A. Mean platelet volume in patients with coronary artery ectasia. Med Sci Monit 2007;13:CR356-359
29. Huczek Z, Kochman J, Filipiak KJ, Horszczaruk GJ, Grabowski M, Piatkowski R, Wilczynska J, Zielinski A, Meier B, Opolski G. Mean Platelet Volume on Admission Predicts Impaired Reperfu-sion and Long-Term Mortality in Acute Myocardial Infarction Treated With Primary Percutaneous Coronary Intervention. J Am Coll Cardiol 2005;46:284 -90
30. Maden O, Kaçmaz F, Çelebi SA, Üreyen Ç, Selçuk MT, Özeke Ö, Erbay AR, Ulusoy F V, Ilkay E. Relation of Admission Mean Platelet Volume with Reperfusion in Acutest Segment Elevation Myocardial Infarction Patients Treated with Fibrinolytic Therapy. MN Cardiology 2008; 15:25-31.
31. Sezer M, Okcular I, Goren T, Oflaz H, Nisanci Y, Umman B, Mercanoglu F, Bilge AK, Meric M, Umman S. Association of haematological indices with the degree of microvascular injury in patients with acute anterior wall myocardial infarction treated with primary percutaneous coronary intervention. Heart 2007; 93:313-8.